Nuclea Biotechnologies Receives $5,000,000 Series C Funding

  • Feed Type
  • Date
    8/2/2012
  • Company Name
    Nuclea Biotechnologies
  • Mailing Address
    105 South Street Pittsfield, MA 01201
  • Company Description
    Nuclea Biotechnologies’ primary mission is to conduct genomic research in the oncology field so as to discover biomarkers and gene or protein expression profiles that are unique to oncologic diseases.
  • Website
    http://www.nucleabiomarkers.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The company will use the proceeds to support clinical trials and new hires related to the development of its fatty acid synthase tests for prostate and breast cancers.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.